RTW Investments, LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:47 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 5,315,514 9.200% |
1,723,528 (+47.98%) |
Filing |
| 2023-02-14 10:04 am Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 3,591,986 7.300% |
992,164 (+38.16%) |
Filing |
| 2022-02-14 08:07 am Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 2,599,822 5.400% |
-1,050,247 (-28.77%) |
Filing |
| 2021-02-12 09:36 am Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 3,650,069 8.670% |
1,190,081 (+48.38%) |
Filing |